v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 28 $ 516
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 328 317
Deferred income taxes 14 (261)
Stock-based compensation expense 7 7
Impairment and (gain) loss on sale of businesses, net (248) (242)
Loss (gain) from early extinguishment of debt 12 (105)
Other non-cash expenses, net 118 134
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:    
Patient accounts receivable (113) 75
Supplies, prepaid expenses and other current assets 40 5
Accounts payable, accrued liabilities and income taxes (160) (86)
Other (81) (83)
Net cash (used in) provided by operating activities (55) 277
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (54) (1)
Purchases of property and equipment (239) (241)
Proceeds from disposition of hospitals and other ancillary operations 1,210 1,012
Proceeds from sale of property and equipment 0 8
Purchases of available-for-sale debt securities and equity securities (87) (107)
Proceeds from sales of available-for-sale debt securities and equity securities 80 87
Purchases of investments in unconsolidated affiliates (1) 0
Increase in other investments (15) (53)
Net cash provided by investing activities 894 705
Cash flows from financing activities:    
Repurchase of restricted stock shares for payroll tax withholding requirements (2) (2)
Deferred financing costs and other debt-related costs (8) (9)
Proceeds from noncontrolling investors in joint ventures 1 2
Redemption of noncontrolling investments in joint ventures 0 (2)
Distributions to noncontrolling investors in joint ventures (129) (120)
Other borrowings 38 16
Issuance of long-term debt 0 2,470
Proceeds from ABL Facility 1,307 3,021
Repayments of long-term indebtedness (2,151) (6,272)
Net cash used in financing activities (944) (896)
Net change in cash and cash equivalents (105) 86
Cash and cash equivalents at beginning of period 260 37
Cash and cash equivalents at end of period 155 123
Supplemental disclosure of cash flow information:    
Interest payments (650) (622)
Income tax payment, net $ (76) $ (192)